Mall Check: Abercrombie & Fitch Attracts Bull Rating From J.P. Morgan
Fluor Analyst Ratings
Abercrombie & Fitch Price Target Raised to $194.00/Share From $167.00 by JP Morgan
Abercrombie & Fitch Analyst Ratings
Lantheus Holdings Analyst Ratings
Jefferies Reaffirms Their Buy Rating on Lantheus (LNTH)
Buy Rating Affirmed for Lantheus Holdings With Enhanced Revenue Projections and Strategic Expansion
Barclays Adjusts Price Target on Fluor to $45 From $39, Maintains Equalweight Rating
Fluor Analyst Ratings
Barclays Sticks to Its Hold Rating for Fluor (FLR)
Fluor Analyst Ratings
Keybanc Upgrades Fluor to Overweight, Announces $57 Price Target
Sprouts Farmers Market Analyst Ratings
Insmed Analyst Ratings
Barclays Keeps Their Buy Rating on Insmed (INSM)
Analyst Ratings For Abercrombie & Fitch
Abercrombie & Fitch Analyst Ratings
Lantheus Holdings Analyst Ratings
Analysts Conflicted on These Healthcare Names: Lantheus (LNTH) and Catalent (CTLT)
Truist Securities Adjusts Price Target on Lantheus Holdings to $141 From $96, Maintains Buy Rating